169 related articles for article (PubMed ID: 38216364)
21. Euglycemic diabetic ketoacidosis: A missed diagnosis.
Nasa P; Chaudhary S; Shrivastava PK; Singh A
World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
[TBL] [Abstract][Full Text] [Related]
22. [Perioperative Ketoacidosis under SGLT2-Inhibitors].
Buck S; Russo SG
Anasthesiol Intensivmed Notfallmed Schmerzther; 2021 Oct; 56(10):704-708. PubMed ID: 34704247
[TBL] [Abstract][Full Text] [Related]
23. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
Allison R; Goldstein D; Musso MW
J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990
[TBL] [Abstract][Full Text] [Related]
24. [Euglycemic Diabetic Ketoacidosis Caused by a Sodium-glucose Co-transporter (SGLT) 2 Inhibitor after Coronary Artery Bypass Grafting].
Kameda Y; Kato M; Inoue B; Yamazaki S; Sahara N; Aoki T; Nagashima Y; Nemoto N; Anzai H; Araki W; Kobayashi N
Kyobu Geka; 2019 May; 72(5):354-357. PubMed ID: 31268032
[TBL] [Abstract][Full Text] [Related]
25. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
[TBL] [Abstract][Full Text] [Related]
26. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors After Cardiac Surgery: A Review of Current Literature.
Branco A; Fatima R; Liblik K; Jackson R; Payne D; El-Diasty M
J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3877-3886. PubMed ID: 35863986
[TBL] [Abstract][Full Text] [Related]
27. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Osafehinti DA; Okoli OJ; Karam JG
AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
Seger CD; Xing H; Wang L; Shin JS
A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
[TBL] [Abstract][Full Text] [Related]
29. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T
J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282
[TBL] [Abstract][Full Text] [Related]
30. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence.
Mehta PB; Robinson A; Burkhardt D; Rushakoff RJ
Endocr Pract; 2022 Sep; 28(9):884-888. PubMed ID: 35753675
[TBL] [Abstract][Full Text] [Related]
31. Euglycemic Ketoacidosis.
Bonora BM; Avogaro A; Fadini GP
Curr Diab Rep; 2020 May; 20(7):25. PubMed ID: 32424730
[TBL] [Abstract][Full Text] [Related]
32. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
[TBL] [Abstract][Full Text] [Related]
33. Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis.
Wan Azman SS; Sukor N; Abu Shamsi MY; Ismail I; Kamaruddin NA
Front Endocrinol (Lausanne); 2022; 13():867647. PubMed ID: 35712244
[TBL] [Abstract][Full Text] [Related]
34. [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors].
Valek R; Von der Mark J
Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):145-148. PubMed ID: 27221094
[TBL] [Abstract][Full Text] [Related]
35. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
Sarno MJF; Hernandez DPF; Matulac MO
Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
[TBL] [Abstract][Full Text] [Related]
36. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report.
Vadasz B; Arazi M; Shukha Y; Koren O; Taher R
J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735
[TBL] [Abstract][Full Text] [Related]
37. Euglycemic diabetic ketoacidosis in a patient on sodium-glucose cotransporter 2 inhibitors.
Hammond DB; Ingram CC
JAAPA; 2023 Sep; 36(9):1-3. PubMed ID: 37668485
[TBL] [Abstract][Full Text] [Related]
38. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: A retrospective cohort study.
Iwasaki Y; Sasabuchi Y; Horikita S; Furukawa T; Shiotsuka J; Lefor AK; Sanui M
BMC Endocr Disord; 2022 Aug; 22(1):209. PubMed ID: 35987618
[TBL] [Abstract][Full Text] [Related]
39. Euglycemic Diabetic Ketoacidosis: A Review.
Modi A; Agrawal A; Morgan F
Curr Diabetes Rev; 2017; 13(3):315-321. PubMed ID: 27097605
[TBL] [Abstract][Full Text] [Related]
40. Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium-glucose cotransporter 2 inhibitor.
Miwa M; Nakajima M; Kaszynski RH; Goto H
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33028568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]